Girish Venkataraman, University of Chicago
Assistant Professor
Chicago, Illinois
girish.venkataraman@uchospitals.edu
Office:
(773) 702-5273
Bio/Research
Dr. Venkataraman's main area of interest is in the identification of prognostic biomarkers in classical Hodgkin lymphoma (cHL). He recently demonstrated that aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with worse outcome. Another recent work demonstrating the ex...
Click to Expand >>
Click to Expand >>
Bio/Research
Dr. Venkataraman's main area of interest is in the identification of prognostic biomarkers in classical Hodgkin lymphoma (cHL). He recently demonstrated that aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with worse outcome. Another recent work demonstrating the expression of CD15- an antigen traditionally restricted to cHLs- in cases of Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) underscores the existence of grey zones between these two otherwise clinically and histologically distinct subtypes of Hodgkin lymphoma.
Click to Shrink <<
Click to Shrink <<